Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Munda Gold Mine Mining Progresses: First Blast June 19, 2025 Empire Metals Limited Announces Warrant Exercise June 13, 2025 Hecla Mining to Sell Casa Berardi Gold Mine... January 28, 2026 Acquisition of “Thompson Falls” High-Grade Antimony Project Adjacent... February 5, 2026 Canadian Investment Regulatory Organization Trade Resumption – PRIZ July 19, 2025 Scoping Study Demonstrates Low Cost ISR Uranium Potential June 5, 2025 Franklin Templeton Advocates for Blockchain Modernization in US$18... January 22, 2026 WPIC: Platinum to Hit Third Annual Deficit as... September 12, 2025 Navigating Uncertainty: How Trump’s Tariffs Are Affecting the... August 28, 2025 Prismo Engages Windfall Geotek for Data Analysis at... August 18, 2025